Overview
Join us for dinner & conversation
Please join us for dinner and conversation during the week of the BIO Europe conference, where we’ll discuss how the Inflation Reduction Act’s drug pricing regulations are impacting M&A deal trends and how they are likely to reshape the strategic landscape of the Biopharma sector.
Our discussion will be led by Duane Wright, Bloomberg Intelligence Policy Analyst, and Sam Fazeli, Director of Research for Global Industries at Bloomberg Intelligence.
Topics will include:
- Impact on Pricing and Topline
- Shifts in Strategies
- Enhanced Due Diligence
- Renewed Interest in Innovative Pipeline/Novel Therapies